Skip to main content

Sapience Therapeutics

Scarsdale, United States

Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs

$2.0M raised
May 2023
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sapience Therapeutics

How much funding has Sapience Therapeutics raised?
Sapience Therapeutics has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in May 2023.
Who are Sapience Therapeutics's investors?
Sapience Therapeutics's investors include Bristol-Myers Squibb, Connectivity Ventures Fund, Kingdon Capital, National Institute of Allergy and Infectious Diseases, Celgene.
Where is Sapience Therapeutics headquartered?
Sapience Therapeutics is headquartered in Scarsdale, United States.
What does Sapience Therapeutics do?
Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs
What stage is Sapience Therapeutics at?
Sapience Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Sapience Therapeutics — Funding & Investors." VCBacked, May 4, 2023, https://www.vcbacked.co/company/sapience-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2023). Sapience Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/sapience-therapeutics
Wikipedia (cite web)
{{cite web |title=Sapience Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sapience-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .